Back to Awarded Treatment Trials
Awarded Trial: 06T-810
Grant ID
06T-810
Illness
Schizophrenia
Primary Drug/Intervention
L-Stepholidine
Primary Dosage
12.5-200 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Mamo
Sample Size
12
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
PET
Results
The grant was terminated.
Publication
N/A
Link
N/A
PI Name
David Mamo
Degree
MD
Center
N/A
Institution
Centre for Addiction and Mental Health
Address
250 College Street
City or Town
Toronto
State or Province
Ontario
Zip or Postal Code
M5T 1R8
Country
Canada
Email Address
david_mamo@camh.net